Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Cellectis

Cellectis

ADVERTISEMENT
News and Trends

Gene-Edited T Cell Therapy Players Battle Safety Doubts

Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…

By Anita Chakraverty
22/10/2021 - 5 minutes
In Depth

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

CAR-T therapy has been hailed as a cure for cancer, but what really is this…

By Clara Rodríguez Fernández
11/10/2021 - 10 minutes
News and Trends

European Cancer Deals Increasingly Focus on Natural Killer Cells

Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene,…

By Kostas Vavitsas
23/02/2021 - 6 minutes
News and Trends

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…

By Victor Kotsev
17/12/2020 - 6 minutes
Best in Biotech

Get to Know the 15 Best Biotech Companies in Paris

Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In…

By Clara Rodríguez Fernández
18/02/2020 - 12 minutes
News and Trends

Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential

An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be…

By Jonathan Smith
14/11/2019 - 2 minutes
News and Trends

French Biotech Develops a New Generation of Safer CAR-T Cells

Cellectis is developing a new type of chimeric antigen receptor that could improve the production…

By Alexander Burik
13/06/2018 - 2 minutes
News and Trends

French CAR-T Developer Raises $164M Despite a Challenging Road

Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in…

By Alexander Burik
11/04/2018 - 3 minutes
In Depth

The Most Important Battle in Gene Editing: CRISPR versus TALEN

Despite all the hype, CRISPR is still not in the clinic as a standalone therapy…

By Editorial Team
13/03/2018 - 6 minutes
News and Trends

French Biotech Gets a CRISPR Patent for CAR-T Research

Update (16/02/2018): On top of the European patent it got last July, Cellectis now also…

By Clara Rodríguez Fernández
16/02/2018 - 2 minutes
News and Trends

Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad

Most CAR-T stocks rose on the news that Big Biotech Celgene has plans to acquire…

By Evelyn Warner
23/01/2018 - 2 minutes
In Depth

An Update on What’s New in the French Biotech Industry

Here's a closer look at the French biotech ecosystem in 2017, which remains one the…

By Alex Dale
17/01/2018 - 4 minutes
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast